|
SLC9A6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.226800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.783190E-04 |
| Normal-vs-Stage2 |
4.218200E-01 |
| Normal-vs-Stage3 |
3.753200E-01 |
| Normal-vs-Stage4 |
5.792300E-02 |
| Stage1-vs-Stage2 |
2.498600E-01 |
| Stage1-vs-Stage3 |
1.143160E-01 |
| Stage1-vs-Stage4 |
5.061000E-01 |
| Stage2-vs-Stage3 |
8.934600E-01 |
| Stage2-vs-Stage4 |
3.041000E-01 |
| Stage3-vs-Stage4 |
1.769390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.215800E-04 |
| Normal-vs-AfricanAmerican |
9.754200E-02 |
| Normal-vs-Asian |
8.578200E-01 |
| Caucasian-vs-AfricanAmerican |
3.737400E-01 |
| Caucasian-vs-Asian |
3.829400E-01 |
| AfricanAmerican-vs-Asian |
4.269200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.48839999994477E-06 |
| Normal-vs-Female |
5.924000E-01 |
| Male-vs-Female |
2.28519999999621E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.603500E-02 |
| Normal-vs-Extreme_Weight |
3.80460000004579E-06 |
| Normal-vs-Obese |
9.802200E-02 |
| Normal-vs-Extreme_Obese |
1.002020E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.295000E-01 |
| Normal_Weight-vs-Obese |
5.638400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.704200E-01 |
| Extreme_Weight-vs-Obese |
3.446200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.668000E-01 |
| Obese-vs-Extreme_Obese |
4.337800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.072800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.717900E-02 |
| Normal-vs-Age(61-80Yrs) |
3.91299999999983E-05 |
| Normal-vs-Age(81-100Yrs) |
8.541000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.297000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.487430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.325600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.558380E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.101600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.172860E-04 |
| Normal-VS-Type2 PRCC |
8.537800E-03 |
| Normal-VS-KIRP CIMP |
8.958800E-01 |
| Normal-VS-Unclassified PRCC |
7.589200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.898400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.549600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.270160E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.784770E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.587900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.781600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.083500E-03 |
| Normal-vs-N1 |
7.192400E-02 |
| Normal-vs-N2 |
6.265200E-01 |
| N0-vs-N1 |
4.557000E-01 |
| N0-vs-N2 |
4.814600E-01 |
| N1-vs-N2 |
7.012600E-01 |
|
|
